Component

Engineered methionine-FTS analogue

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Experimental met-FTS gene delivery expresses an engineered analogue; it does not identify the native human FTS precursor gene.

    Engineered methionine-FTS analogue → Thymulin Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
    experimental_model
    Engineered synthetic expression study.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    Experimental met-FTS gene delivery expresses an engineered analogue; it does not identify the native human FTS precursor gene.
    primary_references
    Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. | 2006 | DOI 10.1038/sj.gt.3302775 | PMID 16617301 | https://doi.org/10.1038/sj.gt.3302775
    source_locator
    Reviewed reference lines 50-50; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 50–50

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Engineered synthetic expression study. · Recorded from source · Recorded from source

    Identification of the peptide does not identify its full native biosynthetic pathway. No sufficiently established endogenous precursor gene and processing sequence was verified in this review. The synthetic **met-FTS** construct used for experimental gene delivery is an engineered analogue; successful expression is not discovery of the native human gene. [Synthetic expression study](https://doi.org/10.1038/sj.gt.3302775)
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Neonatal thymulin immunoneutralization reduced later circulating LH/FSH in mice; engineered met-FTS protected gonadotropin output in thymus-deficient mice.

    Thymulin → Mouse circulating LH and FSH output Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
    experimental_contrast
    {"intervention": "Neonatal thymulin immunoneutralization", "comparator": "Non-neutralized control", "endpoint": "Neonatal thymulin immunoneutralization reduced later circulating LH/FSH in mice; engineered met-FTS protected gonadotropin output in thymus-deficient mice.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Neonatal immunoneutralization and engineered rescue in mouse models; separate from adult dietary depletion.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    Neonatal thymulin immunoneutralization reduced later circulating LH/FSH in mice; engineered met-FTS protected gonadotropin output in thymus-deficient mice.
    primary_references
    Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice. | 2007 | DOI 10.1152/ajpendo.00085.2007 | PMID 17389714 | https://doi.org/10.1152/ajpendo.00085.2007
    source_locator
    Reviewed reference lines 110-110; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 110–110

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Neonatal immunoneutralization and engineered rescue in mouse models; separate from adult dietary depletion. · Recorded from source · Recorded from source

    There is also an experimental loss-of-function result: neonatal thymulin immunoneutralization in mice reduced later circulating LH/FSH, while engineered met-FTS delivery protected gonadotropin output in thymus-deficient mice. This supports a developmental endocrine role in those models; it is not equivalent to adult dietary zinc deficiency or an established human infertility mechanism. [2007 study](https://doi.org/10.1152/ajpendo.00085.2007)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.